[Long-term follow-up of lung function parameters in patients with idiopathic pulmonary fibrosis treated with prednisone and azathioprin or d-penicillamine (author's transl)]
- PMID: 461366
[Long-term follow-up of lung function parameters in patients with idiopathic pulmonary fibrosis treated with prednisone and azathioprin or d-penicillamine (author's transl)]
Abstract
The prognosis of idiopathic pulmonary fibrosis is poor, it amounts to 4-6 years (after beginning of the symptoms). Spontaneous remissions are very rare, the corticosteroid monotherapy shows a certain success in only 11-16-20% of the cases. Therefore, since 1970 we carry out a combined therapy (see above); the results, confirmed by pulmonary function tets (vital capacity, static compliance, pO2 at rest and after exercise) will be presented. In summary: (1) Azathioprin and Prednisone: After a treatment of 2 years: 6 patients improved, 2 deteriorated, 3 died; the corresponding figures after 4 years were 6/1/4, after 6 years 3/-/5, after 8 years 2/-/3; (2) D-Penicillamine and Prednisone: After 2 years 3/2/4, 1 unchanged; after 4 years 1/-/4, 1 unchanged. The results of the therapy are discussed especially regarding prognosis of the disease and used drugs.
Similar articles
-
[Treatment of idiopathic fibrosing alveolitis. Therapeutic experiences with azathioprine-prednisolone and D-penicillamine-prednisolone combination therapy].Schweiz Med Wochenschr. 1977 Feb 12;107(6):184-7. Schweiz Med Wochenschr. 1977. PMID: 834991 German.
-
[Long term development of idiopathic pulmonary fibrosis. Combined therapy with immunodepressors, D-penicillamine and corticosteroids].Bronchopneumologie. 1979 May-Jun;29(3):249-54. Bronchopneumologie. 1979. PMID: 509328 French. No abstract available.
-
[Idiopathic fibrosing alveolitis].Fortschr Med. 1977 Sep 22;95(25):2157-61. Fortschr Med. 1977. PMID: 914141 German.
-
[Diffuse fibrosing alveolitis (author's transl)].Z Erkr Atmungsorgane. 1981 May;157(2):147-51. Z Erkr Atmungsorgane. 1981. PMID: 7032088 Review. German. No abstract available.
-
Current perspectives on the treatment of idiopathic pulmonary fibrosis.Proc Am Thorac Soc. 2006 Jun;3(4):330-8. doi: 10.1513/pats.200602-016TK. Proc Am Thorac Soc. 2006. PMID: 16738197 Review.
Cited by
-
Idiopathic interstitial pneumonias: progress in classification, diagnosis, pathogenesis and management.Trans Am Clin Climatol Assoc. 2004;115:43-76; discussion 76-8. Trans Am Clin Climatol Assoc. 2004. PMID: 17060957 Free PMC article. Review.
-
Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives.Multidiscip Respir Med. 2024 Jun 13;19(1):982. doi: 10.5826/mrm.2024.982. Multidiscip Respir Med. 2024. PMID: 38869027 Free PMC article.
-
[75-year old female with progressive idiopathic lung fibrosis].Med Klin (Munich). 2010 Dec;105(12):952-8. doi: 10.1007/s00063-010-1163-y. Epub 2011 Jan 16. Med Klin (Munich). 2010. PMID: 21240597 German.
-
Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.Thorax. 1989 Apr;44(4):280-8. doi: 10.1136/thx.44.4.280. Thorax. 1989. PMID: 2669218 Free PMC article. Clinical Trial.